Predictive Model for Secundum Atrial Septal Defect Closure with Pulmonary Artery Hypertension in Adult: When to Close
DOI:
https://doi.org/10.1532/hsf.1914Keywords:
Adult, Atrial septal defect, Pulmonary hypertensionAbstract
Background: Secundum atrial septal defect (SASD) closure is contraindicated in the presence of severe pulmonary artery hypertension (PAH). However, there is no consensus on the threshold of severe PAH, in terms of mean pulmonary artery pressure (mPAP), which would contraindicate for defect closure surgery in adults. Furthermore, PAH can persist, or even increase in severity, after the closure. The aim of this study was to produce a predictive model correlating mPAP in adult SASD patients with PAH after defect closure surgery.
Methods: Between January 2014 and March 2017, 29 consecutive adult SASD patients who had PAH and underwent defect closure surgery were included in the study. Age, right atrium (RA) dimension, right ventricle (RV) dimension, and mPAP before surgery were analyzed using multiple regression to produce the model.
Results: Multiple regression produced the following model: mPAP prediction = (0.24)(Age) + (0.06)(mPAP before surgery) + (0.17)(RA dimension) + (0.47)(RV dimension) – 13.79 (P = .0008). The mPAP prediction was compared to mPAP of the patients six to nine months after surgery, and showed no significant difference (P = .9562).
Conclusion: In adult SASD patients with PAH, our model can significantly predict the mPAP after the closure. If the predicted mPAP is within its normal range, the closure is indicated.
References
Engelfriet P, Meijboom F, Boersma E, et al. 2008. Repaired and open atrial septal defect type II in adulthood: an epidemiological study of a large european cohort. Int J Cardiol 126:379-85.
Gabriels C, De Meester P, Pasquet A, et al. 2014. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol 176:833-40.
Grapsa J, Gibbs SR, Cabrita IZ, et al. 2012. The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 13:666-72.
Humenberger M, Rosenhek R, Gabriel H, et al. 2011. Benefit of atrial defect closure in adults: impact of age. Eur Heart J 32:553-60.
Jung IH, Lee SY, Lee SJ, et al. 2013. Device closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin receptor antagonist. J Cardiovasc Ultrasound 21:140-4.
Kozlik-Feldman R, Hansmann G, Bonnet D, et al. 2016. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD): expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. Heart 102:ii42-ii48.
Kuijpers JM, Mulder BJM, Bouma BJ. 2015. Secundum atrial septal defect in adults: a practical review and recent developments. Neth Heart J 23:205-11.
Oliveira EC, Amaral CFS, Moura MA, et al. 2008. Testing pulmonar vasoreactivity. J Bras Pneumol 34:838-44.
Sachweh JS, Daebritz SH, Hermanns B, et al. 2006. Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect. Ann Thorac Surg 81:207-13.
Schwerzmann M, Zafar M, McLaughlin PR, et al. 2006. Atrial septal defect closure in a patient with “irre¬versible” pulmonary hypertensive arteriopathy. Int J Cardiol 110:104-7.
van der Linde D, Konings EEM, Slager MA, et al. 2011. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241-7.
Yong G, Khairy P, De Guise P, et al. 2009. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defect: a longitudinal study. Cardiovasc Intervent 2:455-62.
